Drug Shortage Report for SANDOZ CANDESARTAN PLUS

Last updated on 2024-04-04 History
Report ID 199810
Drug Identification Number 02327902
Brand name SANDOZ CANDESARTAN PLUS
Common or Proper name CANDESARTAN PLUS
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL
Strength(s) 12.5MG 16MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30TAB UD
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-07-24
Estimated end date 2024-07-26
Actual end date 2024-04-03
Shortage status Resolved
Updated date 2024-04-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2024-04-04 English Compare
v23 2024-04-03 French Compare
v22 2024-04-03 English Compare
v21 2024-03-25 French Compare
v20 2024-03-25 English Compare
v19 2024-03-05 French Compare
v18 2024-03-05 English Compare
v17 2024-02-26 French Compare
v16 2024-02-26 English Compare
v15 2024-02-26 English Compare
v14 2024-01-23 French Compare
v13 2024-01-23 English Compare
v12 2023-11-13 French Compare
v11 2023-11-13 English Compare
v10 2023-10-10 French Compare
v9 2023-10-10 English Compare
v8 2023-10-02 French Compare
v7 2023-10-02 English Compare
v6 2023-08-29 French Compare
v5 2023-08-29 English Compare

Showing 1 to 20 of 24